Annual Retained Earnings
-$486.80 M
-$87.68 M-21.97%
December 31, 2023
Summary
- As of February 8, 2025, ALGS annual retained earnings is -$486.80 million, with the most recent change of -$87.68 million (-21.97%) on December 31, 2023.
- During the last 3 years, ALGS annual retained earnings has fallen by -$312.06 million (-178.58%).
- ALGS annual retained earnings is now -3393.84% below its all-time high of -$13.93 million, reached on December 31, 2018.
Performance
ALGS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$535.86 M
-$19.26 M-3.73%
September 30, 2024
Summary
- As of February 8, 2025, ALGS quarterly retained earnings is -$535.86 million, with the most recent change of -$19.26 million (-3.73%) on September 30, 2024.
- Over the past year, ALGS quarterly retained earnings has dropped by -$49.06 million (-10.08%).
- ALGS quarterly retained earnings is now -709.49% below its all-time high of -$66.20 million, reached on December 31, 2019.
Performance
ALGS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ALGS Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -22.0% | -10.1% |
3 y3 years | -178.6% | -27.0% |
5 y5 years | -3393.8% | -27.0% |
ALGS Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -60.6% | at low | -76.8% | at low |
5 y | 5-year | -635.4% | at low | -709.5% | at low |
alltime | all time | -3393.8% | at low | -709.5% | at low |
Aligos Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -$535.86 M(+3.7%) |
Jun 2024 | - | -$516.60 M(-1.0%) |
Mar 2024 | - | -$521.66 M(+7.2%) |
Dec 2023 | -$486.80 M(+22.0%) | -$486.80 M(+6.1%) |
Sep 2023 | - | -$458.90 M(+4.1%) |
Jun 2023 | - | -$440.86 M(+4.5%) |
Mar 2023 | - | -$422.07 M(+5.8%) |
Dec 2022 | -$399.12 M | -$399.12 M(+5.8%) |
Sep 2022 | - | -$377.23 M(+5.2%) |
Jun 2022 | - | -$358.61 M(+5.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | -$338.69 M(+11.8%) |
Dec 2021 | -$303.07 M(+73.4%) | -$303.07 M(+14.2%) |
Sep 2021 | - | -$265.36 M(+14.3%) |
Jun 2021 | - | -$232.23 M(+14.7%) |
Mar 2021 | - | -$202.41 M(+15.8%) |
Dec 2020 | -$174.74 M(+164.0%) | -$174.74 M(+24.5%) |
Sep 2020 | - | -$140.32 M(+31.1%) |
Jun 2020 | - | -$107.02 M(+61.7%) |
Dec 2019 | -$66.20 M(+375.1%) | -$66.20 M |
Dec 2018 | -$13.93 M | - |
FAQ
- What is Aligos Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Aligos Therapeutics?
- What is Aligos Therapeutics annual retained earnings year-on-year change?
- What is Aligos Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly retained earnings year-on-year change?
What is Aligos Therapeutics annual retained earnings?
The current annual retained earnings of ALGS is -$486.80 M
What is the all time high annual retained earnings for Aligos Therapeutics?
Aligos Therapeutics all-time high annual retained earnings is -$13.93 M
What is Aligos Therapeutics annual retained earnings year-on-year change?
Over the past year, ALGS annual retained earnings has changed by -$87.68 M (-21.97%)
What is Aligos Therapeutics quarterly retained earnings?
The current quarterly retained earnings of ALGS is -$535.86 M
What is the all time high quarterly retained earnings for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly retained earnings is -$66.20 M
What is Aligos Therapeutics quarterly retained earnings year-on-year change?
Over the past year, ALGS quarterly retained earnings has changed by -$49.06 M (-10.08%)